Yoshio Hayashi Selected Research

fodrin

2/2008	Epitope mapping of anti-alpha-fodrin antibody in a case of early-onset multiple sclerosis.
7/2006	Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjögren's syndrome: difference in major epitopes between primary and secondary cases.
10/2005	Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
2/2005	Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice.
12/2003	Anti-alpha-fodrin autoantibodies in Moyamoya disease.
6/2003	Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors.
5/2002	Does a lack of reactivity to alpha-fodrin indicate the existence of primary autoimmune pancreatitis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshio Hayashi Research Topics

Disease

16	Neoplasms (Cancer) 03/2021 - 07/2002
9	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2004
6	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2019 - 01/2009
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 05/2008
5	Muscular Dystrophies (Muscular Dystrophy) 01/2021 - 04/2016
5	Autoimmune Diseases (Autoimmune Disease) 05/2010 - 07/2002
4	Obesity 01/2020 - 08/2014
4	Sjogren's Syndrome (Sjogren Syndrome) 10/2005 - 07/2002
3	Muscular Atrophy (Muscle Atrophy) 03/2022 - 01/2011
3	Infections 01/2016 - 12/2004
3	Rheumatoid Arthritis 01/2012 - 05/2004
2	Cachexia 08/2020 - 04/2016
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2015 - 01/2011
2	Hypersensitivity (Allergy) 05/2014 - 04/2011
2	Retinoblastoma (Glioblastoma, Retinal) 01/2009 - 11/2008
2	Malaria 03/2006 - 11/2004
2	Arthritis (Polyarthritis) 12/2004 - 05/2004
1	Phototoxic Dermatitis (Phototoxicity) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Sarcopenia 04/2016
1	Keratoconjunctivitis 01/2014
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2014
1	Immune System Diseases (Immune Disorders) 01/2013
1	Type 1C Limb-Girdle Muscular Dystrophy 01/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2010
1	Hepatitis 03/2010
1	Atrophy 05/2009
1	Multiple Sclerosis 02/2008
1	Body Weight (Weight, Body) 02/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2007
1	Disease Progression 07/2006

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 03/2021 - 01/2004
10	MyostatinIBA 03/2022 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 08/2020 - 02/2005
7	fodrinIBA 02/2008 - 05/2002
6	Nonsense Codon (Nonsense Mutation)IBA 01/2022 - 02/2012
6	Biological ProductsIBA 03/2021 - 07/2005
6	Pharmaceutical PreparationsIBA 01/2016 - 07/2002
5	negamycinIBA 01/2018 - 05/2008
5	Estrogens (Estrogen)FDA Link 05/2010 - 10/2003
5	Amyloid beta-PeptidesIBA 12/2008 - 07/2005
5	AutoantigensIBA 10/2005 - 07/2002
4	ProdrugsIBA 07/2016 - 01/2004
4	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 11/2004
3	Small Interfering RNA (siRNA)IBA 05/2014 - 10/2010
2	neuromedin UIBA 01/2020 - 11/2016
2	DystrophinIBA 01/2018 - 06/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 06/2015
2	EstersIBA 10/2017 - 01/2006
2	NPI 2358IBA 07/2016 - 01/2006
2	TubulinIBA 10/2015 - 01/2006
2	atelocollagenIBA 05/2014 - 01/2011
2	NickelIBA 05/2014 - 04/2011
2	EpitopesIBA 02/2008 - 07/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2006 - 07/2002
2	Taxoids (Taxanes)IBA 04/2005 - 01/2004
2	AutoantibodiesIBA 12/2003 - 06/2003
2	cathepsin SIBA 06/2003 - 08/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2021
1	neuromedin U receptorIBA 01/2020
1	Cell-Penetrating PeptidesIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	GadoliniumIBA 01/2020
1	BoronIBA 01/2020
1	Amino Acids FDA Link 10/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	DipeptidesIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	pyroglutamyl-histidyl-glycineIBA 11/2016
1	Immunoglobulin G (IgG)IBA 07/2016
1	Immunoconjugates (Immunoconjugate)IBA 07/2016
1	HydrazinesIBA 06/2015
1	CaveolinsIBA 01/2015
1	Thymic Stromal LymphopoietinIBA 05/2014
1	GoldIBA 05/2014
1	PalladiumIBA 05/2014
1	Therapeutic UsesIBA 01/2014
1	benzophenoneIBA 07/2012
1	LigandsIBA 01/2012
1	RNA (Ribonucleic Acid)IBA 04/2011
1	p38 Mitogen-Activated Protein KinasesIBA 04/2011
1	MetalsIBA 04/2011
1	LuciferasesIBA 10/2010
1	EnzymesIBA 09/2010
1	Cathepsin LIBA 09/2010
1	NF-kappa B (NF-kB)IBA 03/2010
1	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2009
1	Polychlorinated Dibenzodioxins (TCDD)IBA 05/2009
1	rebamipideIBA 02/2008
1	Endothelin-1 (Endothelin 1)IBA 11/2007
1	Stem Cell FactorIBA 11/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2006

Therapy/Procedure

4	Therapeutics 10/2015 - 07/2002
2	Immunotherapy 03/2021 - 01/2013
1	Boron Neutron Capture Therapy 01/2020
1	Intramuscular Injections 01/2015
1	Transplantation 01/2013
1	Photochemotherapy (Photodynamic Therapy) 05/2008